Trials / Completed
CompletedNCT01216930
Molecular Screening for Lynch Syndrome in Southern Denmark
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- Vejle Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A clinically applicably strategy for molecular screening for Lynch Syndrome has been implemented in the Region of Southern Denmark. Based on sequential analysis with immunohistochemistry and methylation analysis, patients with possible hereditary colorectal cancer are identified. These patients are offered genetic risk assessment and counselling. The study hypothesis is that molecular screening will identify more patients with Lynch Syndrome than the family history alone. Prospective data collection is performed using established clinical databases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | Observation |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-10-01
- Completion
- 2015-09-01
- First posted
- 2010-10-07
- Last updated
- 2015-09-14
Locations
7 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01216930. Inclusion in this directory is not an endorsement.